<DOC>
	<DOCNO>NCT01853280</DOCNO>
	<brief_summary>This pilot study seek evaluate initial evidence effect L-methylfolate supplementation OROS-Methylphenidate pharmacotherapy ADHD symptom associate feature adult ADHD , well tolerability supplementation . The investigator conduct 12-week double-blind randomize placebo-controlled trial L-methylfolate supplement open-label OROS-Methylphenidate ( OROS-MPH ) . The investigator propose examine 40 adult ( age 18-55 ) subject satisfy DSM-IV diagnostic criterion ADHD .</brief_summary>
	<brief_title>L-methylfolate Supplementation OROS-Methylphenidate Pharmacotherapy ADHD Adults</brief_title>
	<detailed_description />
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<mesh_term>Tetrahydrofolates</mesh_term>
	<criteria>1 . Male female adult age 1855 year age . 2 . A diagnosis childhood onset ADHD , meeting age onset criterion accord Diagnostic Statistical Manual Mental Disorders , Fourth Edition ( DSMIV ) , base clinical assessment . Childhood onset define accord establish research criterion , require onset two symptom inattentive impulsive/hyperactive trait age 12 . 3 . A score 24 Adult ADHD Investigator Symptom Report Scale ( AISRS ) . 1 . A history nonresponse intolerance methylphenidate adequate dos determine clinician . 2 . A history intolerance Lmethylfolate supplementation . 3 . Pregnant nursing female . 4 . Serious , unstable medical illness include hepatic , renal , gastroenterological , respiratory , cardiovascular , endocrinologic ( thyroid ) , neurologic ( seizure ) , immunologic , hematologic disease . 5 . Glaucoma . 6 . Clinically unstable psychiatric condition include suicidality , homicidality , bipolar disorder , psychosis , history current mark anxiety , tension agitation potentially exacerbate stimulant , lifetime history clinically serious condition potentially exacerbate stimulant , mania psychosis . 7 . Significant impairment due tic , base clinician judgment . 8 . A family history diagnosis Tourette 's syndrome 9 . Current ( within 3 month ) DSMIV criterion abuse dependence psychoactive substance nicotine . 10 . Multiple adverse drug reaction . 11 . Any concomitant medication consider effective management ADHD ; individual stable treatment agent central nervous system activity allow participate , detailed Concomitant Medication portion protocol . 12 . Current use MAO Inhibitor use within past two week . 13 . Investigator his/her immediate family ; define investigator 's spouse , parent , child , grandparent , grandchild . 14 . Use supplemental folic acid great 400 mcg per day , Lmethylfolate , Omega3 Fatty Acids great 800 mg per day within two week prior baseline study visit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>ADHD</keyword>
	<keyword>Attention Deficit Hyperactivity Disorder</keyword>
	<keyword>Deplin</keyword>
	<keyword>L-methylfolate</keyword>
	<keyword>Natural Treatments</keyword>
	<keyword>Medical Food</keyword>
</DOC>